Wnt1 inducible protein-1 signaling pathway (WISP-1) is a relatively new adipokine involved in many cellular processes, including epithelial mucosa healing. The aim of the study was to compare circulating levels of WISP-1 and other selected adipokines [adiponectin, resistin and retinol-binding protein 4 (RBP-4)] in children with inflammatory bowel disease (IBD) with healthy controls and to investigate possible differences between Crohn's disease patients. (CD) or ulcerative colitis (UC). The study was performed as a case-control study. In addition to adipokines, anthropometric, lipid parameters, markers of inflammation or disease activity were evaluated in all participants. Compared to healthy controls (n=20), significantly lower levels of adiponectin and higher levels of resistin and WISP-1 were found in patients with IBD (n=58). Elevation of WISP-1 was detected only in the CD group (n=31). There were no differences in RBP-4 levels between the groups. Adiponectin, WISP-1 and RBP-4 were independently associated with body mass index only, resistin levels were associated with C-reactive protein levels and leukocyte counts. Adverse adipokines production reflects presence of dysfunctional fat tissue in IBD patients. Higher levels of WISP-1 in CD compared to patients with UC may indicate a specific role for mesenteric adipose tissue in WISP-1 production.

3rd Department of Internal Medicine Nephrology Rheumatology and Endocrinology Faculty of Medicine and Dentistry University Hospital and Palacky University Olomouc Czech Republic

Department of Clinical Biochemistry University Hospital Olomouc Czech Republic

Department of Pediatrics Faculty of Medicine and Dentistry University Hospital and Palacky University Olomouc Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc22014569

003      

CZ-PrNML

005      

20230403113548.0

007      

ta

008      

220602s2022 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.934854 $2 doi

035    __

$a (PubMed)35275697

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Karásková, Eva $u Department of Pediatrics, Faculty of Medicine and Dentistry, University Hospital and Palacky University, Olomouc, Czech Republic $7 xx0096384

245    10

$a Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease / $c E. Karásková, V. Kubickova, M. Velganova-Veghova, M. Geryk, H. Foltenova, D. Karasek

520    9_

$a Wnt1 inducible protein-1 signaling pathway (WISP-1) is a relatively new adipokine involved in many cellular processes, including epithelial mucosa healing. The aim of the study was to compare circulating levels of WISP-1 and other selected adipokines [adiponectin, resistin and retinol-binding protein 4 (RBP-4)] in children with inflammatory bowel disease (IBD) with healthy controls and to investigate possible differences between Crohn's disease patients. (CD) or ulcerative colitis (UC). The study was performed as a case-control study. In addition to adipokines, anthropometric, lipid parameters, markers of inflammation or disease activity were evaluated in all participants. Compared to healthy controls (n=20), significantly lower levels of adiponectin and higher levels of resistin and WISP-1 were found in patients with IBD (n=58). Elevation of WISP-1 was detected only in the CD group (n=31). There were no differences in RBP-4 levels between the groups. Adiponectin, WISP-1 and RBP-4 were independently associated with body mass index only, resistin levels were associated with C-reactive protein levels and leukocyte counts. Adverse adipokines production reflects presence of dysfunctional fat tissue in IBD patients. Higher levels of WISP-1 in CD compared to patients with UC may indicate a specific role for mesenteric adipose tissue in WISP-1 production.

650    _2

$a adipokiny $7 D054392

650    _2

$a adiponektin $7 D052242

650    _2

$a mezibuněčné signální proteiny CCN $x krev $7 D055511

650    _2

$a studie případů a kontrol $7 D016022

650    _2

$a dítě $7 D002648

650    12

$a ulcerózní kolitida $7 D003093

650    _2

$a lidé $7 D006801

650    12

$a idiopatické střevní záněty $7 D015212

650    _2

$a protoonkogenní proteiny $x krev $7 D011518

650    _2

$a resistin $7 D052243

650    _2

$a signální transdukce $7 D015398

655    _2

$a časopisecké články $7 D016428

700    1_

$a Kubíčková, Veronika $7 xx0225011 $u Department of Clinical Biochemistry, University Hospital, Olomouc, Czech Republic

700    1_

$a Velganova-Veghova, Maria $u Department of Pediatrics, Faculty of Medicine and Dentistry, University Hospital and Palacky University, Olomouc, Czech Republic

700    1_

$a Geryk, Miloš $7 xx0252593 $u Department of Pediatrics, Faculty of Medicine and Dentistry, University Hospital and Palacky University, Olomouc, Czech Republic

700    1_

$a Foltenova, Hana $u Department of Pediatrics, Faculty of Medicine and Dentistry, University Hospital and Palacky University, Olomouc, Czech Republic

700    1_

$a Karásek, David $7 stk2007415300 $u Third Department of Internal Medicine – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital and Palacky University, Olomouc, Czech Republic

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 2 (2022), s. 275-284

856    41

$u https://pubmed.ncbi.nlm.nih.gov/35275697 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y p $z 0

990    __

$a 20220602 $b ABA008

991    __

$a 20230403113546 $b ABA008

999    __

$a ok $b bmc $g 1824824 $s 1165790

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 71 $c 2 $d 275-284 $e 20220411 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

LZP    __

$b NLK198 $a Pubmed-20220602